Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study

Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study

To evaluate factors influencing the length of stay in patients undergoing percutaneous left atrial appendage occlusion (LAAO). Patient characteristics, procedural data and the occurrence of serious adverse events were analyzed from the Amplatzer.sup.TM Amulet.sup.TM Occluder Observational Study. Pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2021-08, Vol.16 (8), p.e0255721-e0255721
Hauptverfasser: Piayda, Kerstin, Afzal, Shazia, Nielsen-Kudsk, Jens Erik, Schmidt, Boris, Mazzone, Patrizio, Berti, Sergio, Fischer, Sven, Lund, Juha, Montorfano, Matteo, Hildick-Smith, David, Gage, Ryan, Zhao, Hong, Zeus, Tobias
Format: Artikel
Sprache:eng
Schlagworte:
Atrial fibrillation
Biology and Life Sciences
Cardiac arrhythmia
Cardiology
Care and treatment
Complications
Diagnosis
Embolisms
Embolization
Engineering and Technology
Health risks
Heart failure
Hematoma
Hospital utilization
Hospitals
Length of stay
Medicine and Health Sciences
Mortality
Observational studies
Occlusion
Patients
Pulmonology
Research and Analysis Methods
Stroke
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To evaluate factors influencing the length of stay in patients undergoing percutaneous left atrial appendage occlusion (LAAO). Patient characteristics, procedural data and the occurrence of serious adverse events were analyzed from the Amplatzer.sup.TM Amulet.sup.TM Occluder Observational Study. Patients were divided into three groups: same day (S, 0day, n = 60, 5.6%) early (E, 1day, n = 526, 48.9%), regular (R, 2-3days, n = 338, 31.4%) and late (L, [greater than or equal to]4days, n = 152, 14.1%) discharge and followed up for 60 days. Procedure and device related SAE during the in-hospital stay (S: 0.0% vs. E: 1.0% vs. R: 2.1% vs. L: 23%, p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0255721